SCHEMBL4153190

SCHEMBL4153190

COc1ccc(COc2ccnc(COC(C)=O)c2OCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
ABCB1 P08183 1/20 0.45
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
PDE10A Q9Y233 1/20 0.42
LRRK2 Q5S007 1/20 0.41
RXRA P19793 1/20 0.41
FFAR1 O14842 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAOB P27338 1/20 0.41
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4891121 0.92 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KDM4ECYP2C9CYP2C19
SCHEMBL4687273 0.89 ALDH1A1 (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2MTNR1A
SCHEMBL4159575 0.86 ABCB1 (0.51) ABCB1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL4152950 0.81 RAB9A (0.50) ALDH1A1ABCB1NPC1RAB9APOLB
SCHEMBL4141366 0.81 ALDH1A1 (0.41) ALDH1A1ABCB1NPC1RAB9APOLB
SCHEMBL10678151 0.80 NPC1 (0.50) ABCB1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL10922825 0.79 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2RXRACYP2C9CYP2C19
SCHEMBL4140684 0.78 ABCB1 (0.53) ALDH1A1ABCB1NPC1RAB9AMAOB
SCHEMBL10530981 0.77 RAB9A (0.54) ALDH1A1ABCB1NPC1RAB9APOLB
SCHEMBL4157654 0.76 ABCB1 (0.49) ABCB1NPC1RAB9APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099168-A1 HIV Integrase inhibitors DONGHI MONICA 2009-04-16 US disclosed
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed
EP-1725554-A1 HIV INTEGRASE INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2006-11-29 EP disclosed
WO-2005087766-A1 HIV INTEGRASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161639-A1 Hiv integrase inhibitors DPYD, DUT, TYMP ALDH1A1 1315/4885ABCB1 975/4885NPC1 4324/4885
US-20090099168-A1 HIV Integrase inhibitors DPYD, DUT, QDPR ALDH1A1 1266/4885ABCB1 918/4885NPC1 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.